Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay (Alzheimer's and Dementia, 2019)

(untitled) - Shi, L; Westwood, S; Baird, A; Winchester, L; Dobricic, V; Kilpert, F; Hong, S; Franke, A; Hye, A; Ashton, N; Morgan, A; Bos, I; et al.